How Is Myotonic Dystrophy Daytime Sleepiness Treated?

Excessive daytime sleepiness (EDS) is one of the most common and burdensome symptoms of myotonic dystrophy ^[1]. While it is understandable to want an “energy pill” or stimulant to help you stay awake, the medical standard of care requires evaluating your nighttime breathing before prescribing these medications ^[2][3][4]. Treating excessive sleepiness requires a careful, step-by-step approach that prioritizes the health of your lungs and heart.

Note: It is important to distinguish between sleepiness (the struggle to stay awake) and physical muscle fatigue (muscle exhaustion after activity). While wake-promoting treatments can help keep the brain alert, they do not cure physical muscle fatigue.

The Hidden Cause of Sleepiness: Breathing Weakness

The muscle weakness caused by myotonic dystrophy affects the arms and legs, but it can also affect the diaphragm and the muscles that keep your airway open. This frequently leads to sleep-disordered breathing, including obstructive sleep apnea, central sleep apnea, and nocturnal hypoventilation (shallow breathing that causes low oxygen and a buildup of carbon dioxide in the blood) ^[4][5][6].

Because undetected breathing issues can lead to severe, preventable lung and heart complications ^[7][8], doctors must evaluate this risk first. Masking your sleepiness with a stimulant without addressing underlying breathing problems is dangerous. Doing so leaves the actual cause of your sleepiness untreated and can allow your lung health to silently decline.

First Steps: Breathing Tests and Sleep Studies

To find the root cause of your sleepiness, your care team will recommend two primary evaluations. These are not just one-time hurdles to get medication, but essential, ongoing aspects of regular myotonic dystrophy care:

• Pulmonary Function Tests (PFTs): These tests measure how well your lungs are working and can detect restrictive breathing patterns (when weakened chest muscles prevent the lungs from fully expanding) ^[9][5].
• Polysomnography (Sleep Study): An overnight sleep study is used to monitor your brain waves, oxygen levels, heart rate, and breathing patterns to identify sleep apnea or hypoventilation ^[10][11].

If these tests reveal that you are not breathing well at night, the first-line treatment is non-invasive ventilation (NIV), such as a BiPAP machine (or occasionally a regular CPAP machine, depending on the specific type of apnea found). NIV helps you breathe deeply at night, clearing carbon dioxide and improving oxygen levels in your blood.

Adjusting to a BiPAP mask can be frustrating, especially if you have facial muscle weakness. However, working closely with a respiratory therapist to find a comfortable, well-fitting mask is worth the effort—when nighttime breathing issues are successfully treated, many patients find that their daytime sleepiness improves significantly ^[4][5].

Safeguarding Your Heart: When Are Stimulants Used?

Sometimes, profound daytime sleepiness persists even if your breathing is completely normal or successfully treated with a BiPAP machine. This occurs because myotonic dystrophy can directly affect the central nervous system, altering how your brain regulates sleep and wakefulness ^[12][13]. During this phase, doctors may also run standard blood tests to rule out other easily reversible causes of sleepiness and fatigue, such as thyroid dysfunction.

When sleepiness is driven by the brain rather than the lungs, doctors may prescribe wake-promoting medications or stimulants, such as modafinil ^[14][3]. However, there is an important safety step before starting these drugs: a cardiac evaluation.

Patients with myotonic dystrophy have an increased risk of heart arrhythmias and conduction abnormalities (issues with the heart’s electrical system that affect its rhythm) ^[15][7][16]. Because stimulants can potentially affect the heart, it is essential to have an electrocardiogram (EKG) and clearance from a cardiologist before beginning therapy to ensure your heart is healthy enough for the medication ^[17].